EDGAR Filing Documents for 0001564590-21-015484

Form 8-K - Current report:

SEC Accession No. 0001564590-21-015484

Filing Date

2021-03-25

Accepted

2021-03-25 16:10:34

Documents

Period of Report

2021-03-25

Items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	atha-8k_20210325.htm	8-K	31245
2	EX-99.1	atha-ex991_19.htm	EX-99.1	156774
3	GRAPHIC	gxgbt0cwlykm000001.jpg	GRAPHIC	26439
	Complete submission text file	0001564590-21-015484.txt		225829

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011

Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (206) 221-8112

Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 21772461
SIC: 2836 Biological Products, (No Diagnostic Substances)